Lockheed Martin (NYSE: LMT ) landed a sizable contract award from the U.S. Air Force Thursday, announced as part of the Department of Defense's daily summary of contracts awarded last night.
The contract in question, a $45.6 million modification to an existing contract, instructs Lockheed to perform "Rapid Repair and Response legacy repair" work on Lots 3, 4, and 5 of the C-5 Reliability Enhancement and Re-engining Program (RERP�).
The RERP program aims to modernize the Air Force's fleet of Lockheed C-5 Galaxy transport aircraft by upgrading them with new General Electric (NYSE: GE ) F138-GE-100 jet engines -- an analog to the CF6-80C2 engines that power Air Force One, as well as many Boeing (NYSE: BA ) 747 and 767 commercial jets. With better engines, the Air Force hopes to improve the C-5's "mission capability rate" by as much as 20 percentage points to 75%, allowing the planes to spend more time in service, and less time in the repair shop. It is also hoped that the upgraded planes will be able to carry more cargo (in excess of 270,000 pounds) and take off and land on shorter runways (as short as 5,000 feet).
Hot Dow Dividend Stocks For 2015: Harbinger Group Inc (HRG)
Harbinger Group Inc. (HGI), incorporated on November 3, 2009, is a holding company. The Company's operations are conducted through Spectrum Brands, the Company's subsidiary, which provides branded consumer products, such as batteries, personal care products, small household appliances, pet supplies, and home and garden pest control products, and Fidelity & Guaranty Life Holdings, Inc. (FGL), its wholly owned indirect subsidiary, which provides life insurance and annuity products. In addition, Salus Capital Partners, LLC (Salus), the Company's wholly owned indirect subsidiary, is engaged in the business of providing secured asset-based loans across a range of industries, and Front Street Re Ltd (Front Street), its wholly owned indirect subsidiary provide reinsurance to the specialty insurance sector of fixed, deferred and payout annuities. The Company also own 97.9% of Zap.Com Corporation (Zap.Com), a public shell company, which may seek assets or businesses to acquire or may sell assets and/or liquidate. On November 8, 2012, Spectrum Brands completed acquisition of 56% interest in Shaser Biosciences, Inc.
Spectrum Brands
Spectrum Brands Holdings, Inc. is a global branded consumer products company. As of September 30, 2012, HGI owns approximately 57.4% of Spectrum Brands. Spectrum Brands manufactures and markets alkaline, zinc carbon and hearing aid batteries, herbicides, insecticides and repellents and specialty pet supplies. Spectrum Brands also designs and markets rechargeable batteries, battery-powered lighting products, electric shavers and accessories, grooming products and hair care household appliances. In addition, Spectrum Brands designs, markets and distributes a broad range of branded small appliances and personal care products. Spectrum Brands' manufacturing and product development facilities are located in the United States, Europe, Latin America and Asia. Spectrum Brands' rechargeable batteries and chargers, shaving and grooming products, small household applian! ces, personal care products and portable lighting products are manufactured by third-party suppliers, located in Asia.
Spectrum Brands sells products in approximately 140 countries through a range of trade channels, including retailers, wholesalers and distributors, hearing aid professionals, industrial distributors and original equipment manufacturers (OEMs). Spectrum Brands' branded consumer products have positions in six product categories: consumer batteries; small appliances; pet supplies; home and garden control products; electric shaving and grooming products, and electric personal care products. Spectrum Brands competes in six product categories: consumer batteries, small appliances, pet supplies, home and garden control products, electric shaving and grooming, and electric personal care products. Spectrum Brands' range of products include consumer batteries, including alkaline and zinc carbon batteries, rechargeable batteries and chargers and hearing aid batteries, other specialty batteries and portable lighting products; small appliances, including small kitchen appliances and home product appliances; pet supplies, including aquatic equipment and supplies, dog and cat treats, small animal foods, clean up and training aids, health and grooming products and bedding; home and garden control products, including household insect controls, insect repellents and herbicides; electric shaving and grooming devices, and electric and wet personal care and styling devices.
Spectrum Brands markets and sells a range of alkaline batteries to both retail and industrial customers. Spectrum Brands' alkaline batteries are marketed and sold under the Rayovac and VARTA brands. Spectrum Brands also manufactures alkaline batteries for third parties who sell the batteries under their own private labels. Spectrum Brands' zinc carbon batteries are also marketed and sold under the Rayovac and VARTA brands. Spectrum Brands sells its hearing aid batteries through retail trade channels and directl! y to prof! essional audiologists under brand names and private labels, including Beltone, Miracle Ear and Starkey. Spectrum Brands also sells Nickel Metal Hydride (NiMH) rechargeable batteries and a range of battery chargers under the Rayovac and VARTA brands. Spectrum Brands' other specialty battery products include camera batteries, lithium batteries, silver oxide batteries, keyless entry batteries and coin cells for use in watches, cameras, calculators, communications equipment and medical instruments. Spectrum Brands offers a range of battery-powered, portable lighting products, including flashlights and lanterns for both retail and industrial markets. Spectrum Brands sells its portable lighting products under the Rayovac and VARTA brand names, under other brand names and pursuant to licensing arrangements with third parties.
Spectrum Brands markets and sells a range of products in the branded small household appliances category under the George Foreman, Black & Decker, Russell Hobbs, Farberware, Juiceman, Breadman and Toastmaster brands, including grills, bread makers, sandwich makers, kettles, toaster ovens, toasters, blenders, juicers, can openers, coffee grinders, coffeemakers, electric knives, deep fryers, food choppers, food processors, hand mixers, rice cookers and steamers. Spectrum Brands also markets small home product appliances, including hand-held irons, vacuum cleaners, air purifiers, clothes shavers and heaters, primarily under the Black & Decker and Russell Hobbs brands.
In the pet supplies product category Spectrum Brands markets and sells a range of branded pet supplies for fish, dogs, cats, birds and other small domestic animals. Spectrum Brands has a range of consumer and commercial aquatics products, including integrated aquarium kits, standalone tanks and stands, filtration systems, heaters, pumps, and other equipment, fish food and water treatment products. Spectrum Brands' aquatics brands are Tetra, Marineland, Whisper, Jungle and Instant Ocean. Spectrum Brand! s also se! lls a range of specialty pet products, including dog and cat treats, small animal food and treats, clean up and training aid products, health and grooming aids, bedding products and consumable accessories including privacy tents, litter carpets, crystal litter cartridges, charcoal filters, corn-based litter and replaceable waste receptacles. Spectrum Brands' specialty pet brands include FURminator, 8-in-1, Dingo, Firstrax, Nature's Miracle, Wild Harvest and Littermaid.
In the home and garden control products category Spectrum Brands markets and sells home and garden care products, including household insecticides, insect repellent, herbicides, garden and indoor plant foods and plant care treatments. Spectrum Brands offers a range of household insecticides, such as spider, roach and ant killer, flying insect killer, insect foggers, wasp and hornet killer, flea and tick control products and roach and ant baits. Spectrum Brands also manufactures and markets a range of insect repellent products, which provide protection from insects, especially mosquitoes. These products include both personal repellents, such as aerosols, pump sprays and wipes, as well as area repellents, such as yard sprays, citronella candles and torches. Spectrum Brands' brands in the insect control category include Hot Shot, Cutter, Repel, Black Flag and TAT. Spectrum Brands' herbicides brands include Spectracide, Real-Kill and Garden Safe. Spectrum Brands markets and sells a range of electric shaving and grooming products under the Remington brand name, including men's rotary and foil shavers, beard and mustache trimmers, body trimmers and nose and ear trimmers, women's shavers and haircut kits. Spectrum Brands' electric personal care products, marketed and sold under the Remington, Russell Hobbs, Carmen and Andrew Collinge brand names, include hand-held dryers, curling irons, straightening irons, brush irons, hair setters, facial brushes, skin appliances and electric toothbrushes.
FGL
FGL is an i! ndirectly! wholly owned subsidiary of HGI, is a provider of annuity and life insurance products in the United States. Based in Baltimore, Maryland, FGL operates its annuity and life insurance operations in the United States through its subsidiaries FGL Insurance and FGL NY Insurance. FGL's products are annuities, deferred annuities and life insurance products (including fixed indexed universal life), which it sells, as of September 30, 2012, through a network of approximately 200 insurance marketing organizations (IMOs) representing approximately 19,000 independent agents and managing general agents. As of September 30, 2012, FGL had over 713,000 policyholders nationwide and distributes its products throughout the United States.
FGL's deferred annuities include fixed index annuities and fixed rate annuities. Fixed rate annuities include annual reset and multi-year rate guaranteed policies. FGL, through its insurance subsidiaries, issues a range of deferred annuities (fixed indexed and fixed rate annuities) and immediate annuities. Fidelity & Guaranty Life Insurance Company's (FGL Insurance's) fixed indexed annuities allow contract owners the possibility of earning credits based on the performance of a specified market index without risk to principal. The contracts include a provision for a minimum guaranteed surrender value calculated in accordance with applicable law. During the year ended September 30, 2012 (fiscal 2012), approximately 96% of the fixed indexed annuity sales involved premium bonuses. Fixed rate annuities include annual reset and multi-year rate guaranteed policies. Fixed rate annual reset annuities issued by FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York (FGL NY Insurance) have an annual interest rate. FGL Insurance and FGL NY Insurance also sell single premium immediate annuities (SPIAs), which provide a series of periodic payments for a fixed period of time or for the life of the policyholder. FGL Insurance and FGL NY Insurance offer indexed universal lif! e insuran! ce policies. Holders of universal life insurance policies earn returns on their policies which are credited to the policyholder's cash value account.
In addition to services provided by third-party asset managers, FGL outsources the following functions to third-party service providers, including investment accounting and custody, and underwriting administration of life insurance applications. FGL manages its outsourcing partners and integrates their services into its operations. FGL outsources its new business and existing policy administration for fixed indexed annuity and life products to Transaction Applications Group, Inc., a subsidiary at Dell Inc. (Transaction Group). Under this arrangement, Transaction Group manages all of FGL's call center and processing requirements. FGL has partnered with Hooper Holmes, Inc. (Hooper Holmes) to outsource its life insurance underwriting function. FGL, through its subsidiary FGL Insurance, both cedes reinsurance to other insurance companies and assumes reinsurance from other insurance companies. FGL Insurance provides reinsurance as the reinsurer to four non-affiliate insurance companies.
Salus
Salus, an indirectly wholly owned subsidiary of HGI, is a provider of secured asset-based loans to the middle market across a range of industries with financing throughout the capital structure. The Salus platform also serves as an asset manager to certain institutional investors, such as community and regional banks, insurance companies, family offices, private equity funds and hedge funds who may lack the infrastructure and dedicated competency within senior secured lending. Salus provides secured asset-based loans to the middle market. Salus focuses its credit analysis on the value of accounts receivable and inventory (or other assets) and estimates how much liquidity it can provide against those assets. Salus' loans are used across a range of industries for general working capital or seasonal needs, acquisitions or opportunisti! c situati! ons, trade finance, turnarounds, dividend recaps, refinancing and debtor-in-possession financing.
The Company competes with Energizer Holdings, Inc. (Energizer), The Procter & Gamble Company, Matsushita , Energizer and Mag Instrument, Inc., Mars Corporation, The Hartz Mountain Corporation, Central Garden & Pet Company, The Scotts Miracle-Gro Company, Bayer A.G., S.C. Johnson & Son, Inc., Scotts Company, Henkel KGaA, Koninklijke Philips Electronics NV, Jarden Corporation, DeLonghi America, Euro-Pro Operating LLC, Metro Thebe, Inc., d/b/a HWI Breville, NACCO Industries, Inc., SEB S.A., Conair Corporation, Wahl Clipper Corporation and Helen of Troy Limited.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Harbinger Group (NYSE: HRG ) , whose recent revenue and earnings are plotted below.
Best Managed Healthcare Companies To Buy For 2014: Investors Real Estate Trust(IRET)
Investors Real Estate Trust, a real estate investment trust (REIT), engages in the ownership and operation of income-producing real estate properties in the United States. It owns multi-family residential properties and commercial office, medical, industrial, and retail properties located primarily in the upper midwest states of Minnesota and North Dakota. As of April 30, 2008, the company operated a real estate portfolio of 72 multi-family residential; 65 office; 48 medical; 17 industrial; and 33 retail properties. Investors Real Estate Trust has elected to be taxed as a REIT under the Internal Revenue Code of 1986. As a REIT, the trust is not subject to federal corporate income taxes, if it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1970 and is headquartered in Minot, North Dakota with additional offices in Minneapolis, Minnesota, and Omaha, Nebraska; and Kansas City, Kansas, and St. Louis, Missouri.
Advisors' Opinion:- [By Aaron Levitt]
Why? The boom in Bakken shale drilling. For various REITs it�� a gold mine — and one company that’s definitely taking advantage of this trend is Investors Real Estate Trust (IRET).
- [By Aaron Levitt]
Here are five of the best.
Investors Real Estate Trust (IRET)Real estate investment trusts (REITs) have garnered much attention from investors seeking income in our low interest rate environment. Energy investors may want to hone in on them as well. Specifically, Investors Real Estate Trust (IRET).
Best Managed Healthcare Companies To Buy For 2014: iShares S&P GSCI Commodity-Indexed Trust (GSG)
iShares S&P GSCI Commodity-Indexed Trust (the Trust), formerly iShares GSCI Commodity-Indexed Trust, issues units of beneficial interest, called Shares, representing fractional undivided beneficial interests in its net assets. Substantially all of the assets of the Trust consist of interests in the iShares S&P GSCI Commodity-Indexed Investing Pool LLC (the Investing Pool). The investment objective of the Trust is to seek investment results, through its investment in the Investing Pool, which correspond generally to the performance of the S&P GSCI Total Return Index (the Index). The Investing Pool is a limited liability company. The Investing Pool holds long positions in CERFs, which are futures contracts listed on the Chicago Mercantile Exchange, which have a term of approximately five years after listing and whose settlement at expiration is based on the value of the S&P GSCI Excess Return Index, or S&P GSCI-ER, at that time.
The Index is intended to reflect the performance of a diversified group of commodities. The Index reflects the value of an investment in the S&P GSCI-ER together with a Treasury bill return. The S&P GSCI-ER reflects the returns that are potentially available through a rolling uncollateralized investment in the contracts comprising the S&P GSCI. Barclays Global Investors International, Inc. is the sponsor of the Trust and the manager of the Investing Pool. Barclays Global Investors, N.A. is the trustee of the Trust.
Advisors' Opinion:- [By Charles Sizemore]
But things have changed over the past decade; correlations between commodities have increased. As commodity mutual funds and ETFs such as the PIMCO Commodity Real Return Fund (PCRDX) and iShares S&P GSCI Commodity-Indexed Trust (GSG) have become popular, commodities that once traded largely independently of each other now get lumped together and bought and sold as a group. Also, the financialization of commodities has caused their correlation to stocks to rise as well.
- [By Adam J. Wiederman]
Getty Images Bitcoin made headlines last year when the value of all outstanding pieces of the electronic currency reached nearly $10 billion. It's not just speculators drawn to the new currency. Many businesses are also attempting to cash in on this growth: Several public companies, including Zynga (ZNGA) and Overstock.com (OSTK), accept Bitcoins as a form of payment. Venture capitalist Marc Andreessen's firm has invested nearly $50 million in Bitcoin-related ventures, and it is looking to invest even more. And the Winklevoss twins -- who notoriously accused Facebook's (FB) Mark Zuckerberg of stealing their idea -- have been "in dialogue" with the SEC about opening the first Bitcoin exchange-traded fund, according to Bloomberg. Yet a new survey from TheStreet.com (TST) reveals that 76 percent of consumers are not familiar with Bitcoin -- and 79 percent would never consider owning a currency like it. Does this signal opportunity for savvy investors? Or is this a fad you'd be wise to avoid? The Basics of Bitcoin Bitcoin is a completely unregulated form of currency developed by an anonymous Japanese programmer (according to some apocryphal claims) as a completely digital, peer-to-peer payment system that is independent of national currencies (which, Bitcoin users argue, are all subject to the riskiness of the underlying country). Bitcoins are rewarded throughout the day to a "Bitcoin miner" whose computer solves a series of algorithms quicker than other miners. The puzzles become more difficult over time, so the calculations take longer and the computations require more computing power. There will eventually be a total of 21 million Bitcoins (12.4 million are in circulation today) and we won't reach the point that they are effectively "mined out" until 2040. The value of a Bitcoin is supposed to be market-driven, meaning they're worth whatever the two parties in a transaction value them as. For example, in one of the original Bitcoin transactions, a "mi
Best Managed Healthcare Companies To Buy For 2014: Pernix Therapeutics Holdings Inc (PTX)
Pernix Therapeutics Holdings, Inc. (Pernix), incorporated in November 8, 1996, is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products for pediatric and adult indications in a range of therapeutic areas. It manages a portfolio of branded and generic products and theobromine, a non-codeine, cough suppressant product candidate in development. The Company�� branded products for the pediatrics market include CEDAX, an antibiotic for middle ear infections, NATROBA, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC and a family of prescription treatments for cough and cold (BROVEX, ALDEX and PEDIATEX). It also markets REZYST IM, which is a probiotic blend to promote dietary management. Pernix markets generic products through its wholly owned subsidiary, Macoven Pharmaceuticals, LLC. In January 2013, the Company acquired Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc. In March 2013, the Company acquired Somaxon Pharmaceuticals Inc. In September 2013, Pernix Therapeutics Holdings, Inc. completed the sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.
The Company�� customers consist of drug wholesalers, retail drug stores, mass merchandisers and grocery store pharmacies in the United States. It primarily sells products directly to drug wholesalers, which in turn distribute the products to retail drug stores, mass merchandisers and grocery store pharmacies.
ALDEX Line
ALDEX is a line of antihistamines, decongestants and cough suppressants that are indicated for the temporary relief of respiratory allergies, allergic rhinitis and symptoms of the common cold. The Company�� ALDEX product line is marketed in a range of formulations and combinations using different drug-delivery methodologies to target specific segments of the antihistamine, decongestant and cough suppressant markets. Two used decongestants ar! e phenylephrine and pseudoephedrine.
BROVEX Line
The BROVEX line is a line of antihistamine combinations with the active pharmaceutical ingredient (API) brompheniramine maleate, part of the first generation class of antihistamines called alkylamines that are indicated for the temporary relief of sneezing, itchy, watery eyes, itchy nose or throat, and runny nose due to hay fever or other respiratory allergies. Its BROVEX product line is marketed in a range of formulations and combinations to target specific segments of the antihistamine market. The Company completed the conversion of the BROVEX product family to over-the-counter (OTC) monograph from DESI drugs, in April 2011.
CEDAX Line
CEDAX is a third generation oral cephalosporin indicated for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza or streptococcus pyogenes. The Company sells a range of dosages utilizing both capsule and oral suspension drug delivery methodologies. It also owns a trademark on the name CEDAX in the United States.
NATROBA Line
NATROBA Topical Suspension is a prescription medicine used to treat head lice (pediculosis capitis) in adults and children four years of age and older. NATROBA contains the active ingredient spinosad, which is derived from a naturally occurring soil bacterium.
PEDIATEX Line
As of December 31, 2011, the only product that the Company marketed and sold in its PEDIATEX line is PEDIATEX TD. PEDIATEX TD is an antihistamine/nasal decongestant combination liquid for oral administration. Each 1 milliliter dose contains the API Tripolidine HC1 and Pseudoephedrine HC1. Tripolidine HC1 is a first generation antihistamine in the alkylamine class. Pseudoephedrine, a decongestant, is a sympathomimetic, which acts on alpha-adrenergic receptors in the mucosa of the respiratory tract, producing vasoconstriction and having minimal eff! ect on be! ta-receptors. It therefore functions as an oral nasal decongestant with minimal central nervous system stimulation.
REZYST Line
REZYST IM is a probiotic blend that promotes the dietary management of patients with the distinctive nutritional requirements associated with the gastro-intestinal flora. It is formulated to improve the digestive health of patients by replacing the active cultures altered by diet, stress, and antibiotics.
Product Candidates in Development
Product candidates in development include Theobromine. Theobromine is an alkaloid naturally present in dark chocolate which is an existing human metabolite of caffeine. The Company is working on several other product candidates, which includes a prescription product for the pediatrics market. In March 2012, the Company entered into a product development agreement with a private company for this product.
Advisors' Opinion:- [By Michael Douglass and David Williamson]
Shares of�Pernix Therapeutics� (NASDAQ: PTX ) soared 31% yesterday after the company revealed that it had bought the U.S. rights to�GlaxoSmithKline's (NYSE: GSK ) Treximet (which helps treat migraines in adults) for $250 million upfront (and some potential additional payments later). The importance of this purchase cannot easily be overstate for Pernix -- the company had $85 million in revenue last year, while Treximet on its own brought in $79 million -- and Pernix clearly sees some additional upside potential for the drug, whether it's through a potential indication expansion (to pediatric patients) or through synergies with Pernix's current salesforce.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare stocks gained Wednesday, with Senomyx (NASDAQ: SNMX) leading advancers after the company announced a research agreement with PepsiCo (NYSE: PEP). Among the leading sector stocks, gains came from Pernix Therapeutics Holdings (NASDAQ: PTX), Albany Molecular Research (NASDAQ: AMRI) and Gentiva Health Services (NASDAQ: GTIV).
No comments:
Post a Comment